相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28
Yannick D. Muller et al.
FRONTIERS IN IMMUNOLOGY (2021)
Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma
Eugenia Zah et al.
NATURE COMMUNICATIONS (2020)
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials
Birgit Sawitzki et al.
LANCET (2020)
CAR-Tregs as a Strategy for Inducing Graft Tolerance
Johanna C. Wagner et al.
CURRENT TRANSPLANTATION REPORTS (2020)
Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets
Maaike Rijkers et al.
HAEMATOLOGICA (2019)
Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients
Tobias Deuse et al.
NATURE BIOTECHNOLOGY (2019)
Generation of hypoimmunogenic human pluripotent stem cells
Xiao Han et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Next-generation regulatory T cell therapy
Leonardo M. R. Ferreira et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Chimeric antigen receptor costimulation domains modulate human regulatory T cell function
Angela C. Boroughs et al.
JCI INSIGHT (2019)
Systematic testing and specificity mapping of alloantigen-specific chimeric antigen receptors in regulatory T cells
Nicholas A. J. Dawson et al.
JCI INSIGHT (2019)
Engineering therapeutic T cells to suppress alloimmune responses using TCRs, CARs, or BARs
Antoine Sicard et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells
Yong Chan Kim et al.
JOURNAL OF AUTOIMMUNITY (2018)
Targeting Antigen-Specific B Cells Using Antigen-Expressing Transduced Regulatory T Cells
Ai-Hong Zhang et al.
JOURNAL OF IMMUNOLOGY (2018)
A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants
James M. Mathew et al.
SCIENTIFIC REPORTS (2018)
Reprogramming human T cell function and specificity with non-viral genome targeting
Theodore L. Roth et al.
NATURE (2018)
Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: The next frontier
Jonathan H. Esensten et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Quantifying size and diversity of the human T cell alloresponse
Susan DeWolf et al.
JCI INSIGHT (2018)
FVIII-specific human chimeric antigen receptor T-regulatory cells suppress T-and B-cell responses to FVIII
Jeongheon Yoon et al.
BLOOD (2017)
Transplant trials with Tregs: perils and promises
Qizhi Tang et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Justin Eyquem et al.
NATURE (2017)
Modularly Constructed Synthetic Granzyme B Molecule Enables Interrogation of Intracellular Proteases for Targeted Cytotoxicity
Patrick Ho et al.
ACS SYNTHETIC BIOLOGY (2017)
HLA Epitopes: The Targets of Monoclonal and Alloantibodies Defined
Nadim El-Awar et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2017)
Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants
S. Chandran et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection
D. A. Boardman et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Prevention of Allograft Rejection by Use of Regulatory T Cells With an MHC-Specific Chimeric Antigen Receptor
F. Noyan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
CD28 Costimulation: From Mechanism to Therapy
Jonathan H. Esensten et al.
IMMUNITY (2016)
Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor
Katherine G. MacDonald et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
ABodyBuilder: Automated antibody structure prediction with data-driven accuracy estimation
Jinwoo Leem et al.
MABS (2016)
Affinity for self antigen selects Treg cells with distinct functional properties
Lena Wyss et al.
NATURE IMMUNOLOGY (2016)
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
Jeffrey A. Bluestone et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Attenuation of Donor-Reactive T Cells Allows Effective Control of Allograft Rejection Using Regulatory T Cell Therapy
K. Lee et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen-Specific Regulatory T Cells
Dan Blat et al.
MOLECULAR THERAPY (2014)
Continuous requirement for the TCR in regulatory T cell function
Andrew G. Levine et al.
NATURE IMMUNOLOGY (2014)
Mechanism of Suppression of Chromosomal Instability by DNA Polymerase POLQ
Matthew J. Yousefzadeh et al.
PLOS GENETICS (2014)
Molecular characterisation of the monocytic cell line THP-1 demonstrates a discrepancy with the documented HLA type
Richard Battle et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
A holistic evolutionary and structural study of flaviviridae provides insights into the function and inhibition of HCV helicase
Dimitrios Vlachakis et al.
PEERJ (2013)
Paratome: an online tool for systematic identification of antigen-binding regions in antibodies based on sequence or structure
Vered Kunik et al.
NUCLEIC ACIDS RESEARCH (2012)
In vivo Inhibition of Human CD19-Targeted Effector T Cells by Natural T Regulatory Cells in a Xenotransplant Murine Model of B Cell Malignancy
James C. Lee et al.
CANCER RESEARCH (2011)
Jalview Version 2-a multiple sequence alignment editor and analysis workbench
Andrew M. Waterhouse et al.
BIOINFORMATICS (2009)
Expansion of Human Regulatory T-Cells From Patients With Type 1 Diabetes
Amy L. Putnam et al.
DIABETES (2009)
Redirecting human CD4+CD25+ regulatory T cells from the peripheral blood with pre-defined target specificity
A. A. Hombach et al.
GENE THERAPY (2009)
A Herceptin-Based Chimeric Antigen Receptor with Modified Signaling Domains Leads to Enhanced Survival of Transduced T Lymphocytes and Antitumor Activity
Yangbing Zhao et al.
JOURNAL OF IMMUNOLOGY (2009)
Successful Clinical Islet Isolation Using a GMP-Manufactured Collagenase and Neutral Protease
Gregory L. Szot et al.
TRANSPLANTATION (2009)
A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene
Marie King et al.
CLINICAL IMMUNOLOGY (2008)
Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice
Eran Elinav et al.
GASTROENTEROLOGY (2008)
Production and characterization of adeno-associated viral vectors
Joshua C. Grieger et al.
NATURE PROTOCOLS (2006)
IL-10-dependent suppression of experimental allergic encephalomyelitis by Th2-differentiated, anti-TCR redirected T lymphocytes
DJ Mekala et al.
JOURNAL OF IMMUNOLOGY (2005)
HLA class I and II genotype of the NCI-60 cell lines
S Adams et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
Identification, isolation, and culture of HLA-A2-specific B lymphocytes using MHC class I tetramers
A Mulder et al.
JOURNAL OF IMMUNOLOGY (2003)
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation
M Edinger et al.
NATURE MEDICINE (2003)
The isolation and characterisation of human monoclonal HLA-A2 antibodies from an immune V gene phage display library
NA Watkins et al.
TISSUE ANTIGENS (2000)
分享论文
